Jane Street’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-189,800
| Closed | -$12.9M | – | 10890 |
|
|
2022
Q3 | $12.9M | Buy |
189,800
+91,500
| +93% | +$5.05M | 0.01% | 1460 |
|
|
2022
Q2 | $3.14M | Buy |
98,300
+12,600
| +15% | +$369K | ﹤0.01% | 3370 |
|
|
2022
Q1 | $2.97M | Sell |
85,700
-40,100
| -32% | -$1.2M | ﹤0.01% | 3982 |
|
|
2021
Q4 | $3.68M | Buy |
125,800
+67,800
| +117% | +$2.1M | ﹤0.01% | 3351 |
|
|
2021
Q3 | $1.48M | Sell |
58,000
-6,400
| -10% | -$188K | ﹤0.01% | 5103 |
|
|
2021
Q2 | $2.25M | Buy |
64,400
+15,600
| +32% | +$609K | ﹤0.01% | 4098 |
|
|
2021
Q1 | $1.99M | Sell |
48,800
-17,800
| -27% | -$818K | ﹤0.01% | 4027 |
|
|
2020
Q4 | $2.88M | Buy |
66,600
+33,700
| +102% | +$1.66M | ﹤0.01% | 2874 |
|
|
2020
Q3 | $1.81M | Sell |
32,900
-22,300
| -40% | -$1.42M | ﹤0.01% | 3196 |
|
|
2020
Q2 | $3.48M | Buy |
55,200
+3,600
| +7% | +$247K | ﹤0.01% | 2298 |
|
|
2020
Q1 | $2.64M | Sell |
51,600
-69,600
| -57% | -$4.66M | ﹤0.01% | 1741 |
|
|
2019
Q4 | $9.63M | Buy |
+121,200
| New | +$7.18M | 0.01% | 664 |
|
|
2019
Q3 | – | Sell |
-24,600
| Closed | -$1.29M | – | 5987 |
|
|
2019
Q2 | $1.29M | Buy |
+24,600
| New | +$1.41M | ﹤0.01% | 2355 |
|
|
2019
Q1 | – | Sell |
-11,400
| Closed | -$468K | – | 5864 |
|
|
2018
Q4 | $468K | Buy |
+11,400
| New | +$427K | ﹤0.01% | 3537 |
|
|
2018
Q3 | – | Sell |
-7,900
| Closed | -$357K | – | 5906 |
|
|
2018
Q2 | $357K | Buy |
+7,900
| New | +$360K | ﹤0.01% | 3953 |
|
|
2018
Q1 | – | Sell |
-8,600
| Closed | -$338K | – | 5618 |
|
|
2017
Q4 | $338K | Buy |
+8,600
| New | +$321K | ﹤0.01% | 3621 |
|
Other funds holding GBT
Jane Street's GBT Position: Q4 2022 in Review
Jane Street sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 63,922 shares — an estimated $4.35M sold.
Jane Street first reported a position in GBT in Q4 2015 and held it in 22 quarters. The position peaked at $7.34M in Q2 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.
- Jane Street reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
- Jane Street sold 63,922 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $4.35M.
- Jane Street first reported a position in Global Blood Therapeutics, Inc. in Q4 2015 and held it in 22 quarters.
- Jane Street's Global Blood Therapeutics, Inc. position peaked at $7.34M in Q2 2022.
- 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.
Based on Jane Street's 13F filing for Q4 2022, filed 15 Feb 2023.